Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Net Cash Flow (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Net Cash Flow for 6 consecutive years, with $241.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 105.3% year-over-year to $241.2 million, compared with a TTM value of -$1.2 billion through Dec 2025, up 86.34%, and an annual FY2025 reading of -$3.8 billion, down 178.75% over the prior year.
  • Net Cash Flow was $241.2 million for Q4 2025 at Roivant Sciences, up from -$2.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $5.0 billion in Q4 2023 and bottomed at -$4.6 billion in Q4 2024.
  • Average Net Cash Flow over 5 years is -$408.7 million, with a median of -$133.3 million recorded in 2021.
  • The sharpest move saw Net Cash Flow skyrocketed 1036.57% in 2023, then plummeted 14574.37% in 2024.
  • Year by year, Net Cash Flow stood at $84.5 million in 2021, then crashed by 731.07% to -$533.0 million in 2022, then surged by 1036.57% to $5.0 billion in 2023, then plummeted by 191.15% to -$4.6 billion in 2024, then soared by 105.3% to $241.2 million in 2025.
  • Business Quant data shows Net Cash Flow for ROIV at $241.2 million in Q4 2025, -$2.7 million in Q3 2025, and -$1.5 billion in Q2 2025.